Biotech Archives - Page 725 of 795

1 minute read

This Small Cap Cancer Stock Gets An Upgrade And Price Target Bump On ‘Clinical Programs Progress’

August 29, 3:52 PM

HC Wainwright updated its model on Calithera Biosciences Inc (NASDAQ:CALA), reflecting the recent Q2 earnings with no revenues and a net loss of…

CALA

1 minute read

BioCryst Pharmaceuticals Granted Orphan Drug Designation For The Treatment Of Fibrodysplasia Ossificans Progressiva

By Benzinga Newsdesk

August 29, 2:49 PM

https://www.scribd.com/document/589941834/BCRX-Orphan-Drug

BCRX

1 minute read

HC Wainwright Raises Price For This Lung Disease Stock On First Pivotal Readout

By Vandana Singh

August 29, 2:48 PM

Earlier this month, Verona Pharma plc (NASDAQ:VRNA) reported positive data from the ENHANCE-2 Phase 3 trial of ensifentrine, the company’s lead drug…

VRNA

1 minute read

HC Wainwright Bullish On This Small Cap Stock As Enrollment Starts In Pivotal Skin Disease Trial

By Vandana Singh

August 29, 2:33 PM

Earlier this month, Timber Pharmaceuticals Inc (NYSE:TMBR) reported that the first four patients had been enrolled in the Phase 3 ASCEND study…

TMBR

2 minute read

FDA
News

Cabaletta Bio To Present Data At 31st EADV Congress And Provides Update On DesCAARTes Trial

By Benzinga Newsdesk

August 29, 2:04 PM

abaletta Bio, Inc. (NASDAQ:CABA), a clinical-stage biotechnology company focused on the discovery and development of targeted cell therapies for patients with autoimmune diseases, today announced that it will present new

CABA

1 minute read

Bayer’s Kidney Disease Drug Disappoints On Cutting Cardiovascular Death

By Vandana Singh

August 29, 1:47 PM

Bayer AG (OTC:BAYRY) reported disappointing results from its approved med Kerendia (finerenone) didn’t reach significance on all-cause mortality in a pooled…

BAYRY

1 minute read

Philips Recalls Some Ventilators Over Contaminated Plastic Component

By Vandana Singh

August 29, 1:43 PM

The FDA is alerting patients, caregivers, and health care providers that Koninklijke Philips NV (NYSE:PHG) Respironics recalled certain bi-level positive airway pressure…

PHG

1 minute read

FDA
News

Moleculin Biotech Granted FDA Orphan Drug Designation For ‘an acetic acid diester of 2-deoxy-D-glucose’

By Benzinga Newsdesk

August 29, 11:49 AM

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=896722

MBRX

1 minute read

TRACON Secures FDA Nod For Early-Stage Study In Soft-Tissue Cancer

By Vandana Singh

August 29, 11:45 AM

The FDA has signed off TRACON Pharmaceuticals Inc’s (NASDAQ:TCON) initiation of a Phase 1/2 trial of YH001 in combination with envafolimab…

TCON

1 minute read

Alnylam Posts Mid-Stage Study Data From Regeneron-Partnered Kidney Disease Drug

By Vandana Singh

August 29, 11:40 AM

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) announced results from a Phase 2 study of cemdisiran for immunoglobulin A nephropathy (IgAN). Cemdisiran is an…

ALNY